Market Update

H1 2019 Life Sciences Software Market Update

Madison Park Group (MPG) actively tracks the life sciences software landscape and has been instrumental in strategic deals across the drug development & commercial spectrum.

Through MPG’s time in the space, we’ve noticed a number of trends and developments:

  • Virtual clinical trial applications are gaining significant traction as organizations aim to increase the efficiency of patient recruiting
  • Artificial intelligence (AI) and machine learning (ML) applications continue to pour into the life science industry, attracting high-profile, early-stage investments
  • Multiple large acquisitions and aggressive sponsor buyout activity illustrates bullish buyer views of the life science software market
  • Pharma IT spend will accelerate as a result of continuous development of novel therapies, changing policies in insurance and pricing, and an ongoing need for operational efficiency

Practice Leaders

Rohan Khanna
Managing Director

Jonathan Adler
Managing Director

Get in touch with us

Contact Us

  • Hidden
  • This field is for validation purposes and should be left unchanged.